160 related articles for article (PubMed ID: 30954648)
1. The NQO1/PKLR axis promotes lymph node metastasis and breast cancer progression by modulating glycolytic reprogramming.
Yang Y; Zhu G; Dong B; Piao J; Chen L; Lin Z
Cancer Lett; 2019 Jul; 453():170-183. PubMed ID: 30954648
[TBL] [Abstract][Full Text] [Related]
2. SPOCK1/SIX1axis promotes breast cancer progression by activating AKT/mTOR signaling.
Xu M; Zhang X; Zhang S; Piao J; Yang Y; Wang X; Lin Z
Aging (Albany NY); 2020 Dec; 13(1):1032-1050. PubMed ID: 33293473
[TBL] [Abstract][Full Text] [Related]
3. Clinical implications of high NQO1 expression in breast cancers.
Yang Y; Zhang Y; Wu Q; Cui X; Lin Z; Liu S; Chen L
J Exp Clin Cancer Res; 2014 Feb; 33(1):14. PubMed ID: 24499631
[TBL] [Abstract][Full Text] [Related]
4. Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin β4/SNAI1/SIRT3 signaling pathway.
Wang S; Li J; Xie J; Liu F; Duan Y; Wu Y; Huang S; He X; Wang Z; Wu X
Oncogene; 2018 Jul; 37(30):4164-4180. PubMed ID: 29706653
[TBL] [Abstract][Full Text] [Related]
5. β-lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers.
Yang Y; Zhou X; Xu M; Piao J; Zhang Y; Lin Z; Chen L
Sci Rep; 2017 Jun; 7(1):2681. PubMed ID: 28578385
[TBL] [Abstract][Full Text] [Related]
6. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer.
Xu JH; Wang Y; Xu D
Cancer Biomark; 2019; 25(2):193-201. PubMed ID: 31104012
[TBL] [Abstract][Full Text] [Related]
7. NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer.
Cui X; Jin T; Wang X; Jin G; Li Z; Lin L
Oncol Rep; 2014 Dec; 32(6):2589-95. PubMed ID: 25231218
[TBL] [Abstract][Full Text] [Related]
8. LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro.
Xiao M; Yang S; Meng F; Qin Y; Yang Y; Jia S; Cai X; Li C; Huang Y; Ning X
Cell Physiol Biochem; 2017; 41(3):1072-1082. PubMed ID: 28245476
[TBL] [Abstract][Full Text] [Related]
9. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
10. MiR-361-5p inhibits glycolytic metabolism, proliferation and invasion of breast cancer by targeting FGFR1 and MMP-1.
Ma F; Zhang L; Ma L; Zhang Y; Zhang J; Guo B
J Exp Clin Cancer Res; 2017 Nov; 36(1):158. PubMed ID: 29132384
[TBL] [Abstract][Full Text] [Related]
11. Significant association of PKM2 and NQO1 proteins with poor prognosis in breast cancer.
Zhu K; Li Y; Deng C; Wang Y; Piao J; Lin Z; Chen L
Pathol Res Pract; 2020 Nov; 216(11):153173. PubMed ID: 32841776
[TBL] [Abstract][Full Text] [Related]
12. S100A2 promotes glycolysis and proliferation via GLUT1 regulation in colorectal cancer.
Li C; Chen Q; Zhou Y; Niu Y; Wang X; Li X; Zheng H; Wei T; Zhao L; Gao H
FASEB J; 2020 Oct; 34(10):13333-13344. PubMed ID: 32816365
[TBL] [Abstract][Full Text] [Related]
13. NQO1 Deficiency Leads Enhanced Autophagy in Cisplatin-Induced Acute Kidney Injury Through the AMPK/TSC2/mTOR Signaling Pathway.
Kim TW; Kim YJ; Kim HT; Park SR; Lee MY; Park YD; Lee CH; Jung JY
Antioxid Redox Signal; 2016 May; 24(15):867-83. PubMed ID: 26935540
[TBL] [Abstract][Full Text] [Related]
14. FLI1 accelerates leukemogenesis through transcriptional regulation of pyruvate kinase-L/R and other glycolytic genes.
Sheng D; Chen B; Wang C; Xiao X; Hu A; Liu W; Kuang Y; Sample KM; Zacksenhaus E; Gajendran B; Pan W; Ben-David Y
Med Oncol; 2022 Dec; 40(2):69. PubMed ID: 36586017
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of NAD(P)H: Quinone Oxidoreductase 1 Inhibits Hepatocellular Carcinoma Cell Proliferation and Induced Apoptosis by Activating AMPK/PGC-1α Pathway.
Zhang X; Han K; Yuan DH; Meng CY
DNA Cell Biol; 2017 Apr; 36(4):256-263. PubMed ID: 28191864
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D
Santos JM; Khan ZS; Munir MT; Tarafdar K; Rahman SM; Hussain F
J Nutr Biochem; 2018 Mar; 53():111-120. PubMed ID: 29216499
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-mesenchymal transition induces similar metabolic alterations in two independent breast cancer cell lines.
Kondaveeti Y; Guttilla Reed IK; White BA
Cancer Lett; 2015 Aug; 364(1):44-58. PubMed ID: 25917568
[TBL] [Abstract][Full Text] [Related]
19. Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways.
Yang L; Hou Y; Yuan J; Tang S; Zhang H; Zhu Q; Du YE; Zhou M; Wen S; Xu L; Tang X; Cui X; Liu M
Oncotarget; 2015 Sep; 6(28):25755-69. PubMed ID: 26342198
[TBL] [Abstract][Full Text] [Related]
20. CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms.
Xiao G; Wang X; Wang J; Zu L; Cheng G; Hao M; Sun X; Xue Y; Lu J; Wang J
Oncotarget; 2015 Jun; 6(16):14165-78. PubMed ID: 25909173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
